{
  "id": "bb73290195305d0c",
  "title": "From Croatia to MAHA: How an unapproved drug became the next hot peptide",
  "description": "BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction \u2013 and attention from MAHA.",
  "content": "BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction \u2013 and attention from MAHA.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/03/bpc-157-peptide-science-safety-regulatory-questions/?utm_campaign=rss",
  "published_at": "2026-02-03T09:30:00+00:00",
  "fetched_at": "2026-02-04T00:26:40.270602+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "fda",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "From Croatia to MAHA: How an unapproved drug became the next hot peptide",
    "description": "BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction \u2013 and attention from MAHA.",
    "url": "https://www.statnews.com/2026/02/03/bpc-157-peptide-science-safety-regulatory-questions/?utm_campaign=rss",
    "published": "2026-02-03T09:30:00+00:00",
    "source": "STAT"
  }
}